China Biologic Products, Inc.·4

Sep 17, 4:40 PM ET

Gao David 4

4 · China Biologic Products, Inc. · Filed Sep 17, 2012

Insider Transaction Report

Form 4
Period: 2012-09-13
Gao David
Director
Transactions
  • Purchase

    Common Stock

    2012-09-13$8.93/sh+5,000$44,64112,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in the open market at prices ranging from $8.89 to $9.00, inclusive. The Reporting Person undertakes to provide to any securityholders of China Biologic Products, Inc. (the "Issuer") or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES